Athira

Who may qualify

Persons who purchased or otherwise acquired Athira Pharma, Inc. publicly traded common stock during the class period (September 17, 2020 through June 17, 2021) and were damaged thereby.

This summary is based on available official settlement sources. The settlement administrator determines eligibility and payment approval.

New to the terms? Plain-English: claim deadline, proof of purchase, administrator, pro rata.

Important dates

Claim deadline: September 6, 2024 (closed)
Exclusion deadline: September 6, 2024 (passed)
Objection deadline: September 6, 2024 (passed)

Proof requirements

Proof requirement is currently marked as Yes.

Review the official claim form before submitting any information.

How to file this claim

This is a securities class action settlement for investors who purchased Athira Pharma common stock during the class period. The claims filing deadline has already passed and the court has granted final approval, so class members who submitted valid claim forms by the deadline are eligible for payment.

Confirm you purchased Athira Pharma, Inc. common stock during the class period (September 17, 2020 through June 17, 2021)
Note that the claims filing deadline has already passed — contact the claims administrator if you believe you have a valid late claim or question about your status
Visit the settlement website at www.athirasecuritiessettlement.com for current case status and payment information

Watch out for

The claims filing deadline has passed; the settlement website states 'The claims filing deadline for this case has passed'
Only class members who submitted valid claim forms by the deadline are eligible for payments
If you opted out of the class by submitting a written exclusion request, you are not eligible for settlement benefits

We prepare — you file on the official site yourself. This is not legal advice and is not an eligibility decision; the administrator and court decide.

How do I file a claim for this settlement?

This record no longer has an open public claim form — confirm the current status and any next steps on the official source.

Confirm you are within the eligible group described in the official notice — the settlement administrator determines eligibility.
Gather any documents the official form asks for — this settlement marks proof as Yes.
Open the official claim form or settlement website run by Strategic Claims Services.
Submit accurate information through the official settlement administrator or government source before September 6, 2024.
Save your confirmation number if one is provided, then watch the payment status for distribution updates.

New to settlement claims? How to file safely →

Worried it might be fake? Run the 60-second legitimacy check →

How we verified this record

Verification in progress 7 / 8 fields checked

Claim deadline the official settlement website · Jun 18, 2026
Payout details the official settlement website · Jun 18, 2026
Eligibility the official settlement website · Jun 18, 2026
Proof requirement the official settlement website · Jun 18, 2026
Administrator the official settlement website · Jun 19, 2026
Court case the official settlement website · Jun 18, 2026
Payment status the official settlement website · Jun 18, 2026
Official claim link queued for re-check

Every published record clears our source-verification bar; remaining fields are checked one by one on our weekly re-verification pass.

Checked fields are matched against a named official source and re-checked on a schedule. We show the authority and the date, never our internal evidence link.

Claim deadline
September 6, 2024

Verified Jun 18, 2026 · against the official settlement website
Eligibility summary
Persons who purchased or otherwise acquired Athira Pharma, Inc. publicly traded common stock during the class period (September 17, 2020 through June 17, 2021) and were damaged thereby.

Verified Jun 18, 2026 · against the official settlement website
Proof requirement
Yes

Verified Jun 18, 2026 · against the official settlement website
Payment status
Final approval pending

Verified Jun 18, 2026 · against the official settlement website

The Court has granted Plaintiffs' unopposed motion for final approval of the Settlement. Class members who submitted valid claim forms by the deadline are eligible for payments from the settlement fund.
Estimated payout
$10,000,000 in cash

Verified Jun 18, 2026 · against the official settlement website
Administrator
Strategic Claims Services

Verified Jun 19, 2026 · against the official settlement website

Show all 7 more verified fields

Objection deadline
September 6, 2024

Verified Jun 18, 2026 · against the official settlement website

BY SEPTEMBER 6, 2024 IF YOU ARE NOT REPRESENTED BY COUNSEL. BY OCTOBER 11, 2024 IF YOU ARE REPRESENTED BY COUNSEL.
Opt-out deadline
September 6, 2024

Verified Jun 18, 2026 · against the official settlement website
Class period start
September 17, 2020

Verified Jun 18, 2026 · against the official settlement website
Class period end
June 17, 2021

Verified Jun 18, 2026 · against the official settlement website
Court
United States District Court for the Western District of Washington

Verified Jun 18, 2026 · against the official settlement website
Court case number
2:21-Cv-00861-TSZ

Verified Jun 18, 2026 · against the official settlement website

Case No. 2:21-Cv-00861-TSZ (W.D. Wash.)
Case name
Athira Pharma Securities Litigation

Verified Jun 19, 2026 · against the official settlement website

Common questions

Is the Athira settlement legitimate?

Yes — the Athira settlement is a real claims process that SettleSignal tracks from its official source. It is administered by Strategic Claims Services under case 2:21-Cv-00861-TSZ in United States District Court for the Western District of Washington. File only through the official settlement website (www.athirasecuritiessettlement.com); a genuine settlement administrator never charges a fee to file. SettleSignal last checked this record against the official source on June 19, 2026. Always confirm the current details on the official site before filing.

Who may qualify for this settlement?

Persons who purchased or otherwise acquired Athira Pharma, Inc. publicly traded common stock during the class period (September 17, 2020 through June 17, 2021) and were damaged thereby.

What is the claim deadline?

The claim deadline is September 6, 2024. Confirm the current deadline on the official settlement source before filing.

Do I need proof to claim?

Proof requirement: Yes. The settlement administrator determines what documentation, if any, is required.

What is the current payment status?

Current payment status: Final approval pending. Payments are issued by the administrator after the court process concludes.

When will Athira pay out?

Current payment status: Final approval pending. Class-action payouts typically begin only after final approval and any appeals. See our payout timeline guide.

Where is the official Athira claim form?

The official claim form is hosted by the settlement administrator, Strategic Claims Services. Use the 'Open official claim form' button on this page — never pay a fee to file.

Privacy & Tracking

Claim window closed

Ampac Holdings $318,825 Illinois BIPA Class Action Settlement

If you worked at Ampac Holdings in Illinois and used a fingerprint timeclock during the class period, you were part of a BIPA settlement that estimated approximately $572.36 per qualifying claimant. The claim deadline was June 15, 2026, so the filing window has now closed.

Aqua Illinois $12.5 Million University Park Water Settlement

If you got water from Aqua Illinois in University Park, IL between December 9, 2017 and July 10, 2024, or received a 'Do Not Consume' or 'Lead Advisory' notice, you can file a claim for cash from a $12.5 million settlement. You need to submit a claim form by July 6, 2026.

Banana Republic $1.95M Labor Class Action Settlement

If you worked as a non-exempt retail store employee at Banana Republic or Gap in California between October 27, 2022 and July 4, 2025, you're automatically in this $1.95 million settlement. You don't have to file anything — a payment will be calculated from company records and sent to you.

Potential payout

Amount not yet set

Securities class action

Claim window closed

Ginkgo Securities Litigation

Purchasers of Ginkgo Bioworks Holdings, Inc.

Settlement fund

$17.8M

Closed Nov 21, 2024

Disclaimer

This service summarizes publicly available settlement information and links to official settlement sources. We are not a law firm, do not provide legal advice, do not submit claims on your behalf, and do not determine eligibility or payout approval. Only file a claim if the information you provide is accurate.

Change log

June 20, 2026 — Settlement published after verification.
June 19, 2026 — Verified field details updated from an official source.
June 18, 2026 — Verified field details updated from an official source.